XLO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Xilio Therapeutics Inc (XLO).


$41.98M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

XLO Market Cap. (MRY)


XLO Shares Outstanding (MRY)


XLO Assets (MRY)


Total Assets

$71.08M

Total Liabilities

$53.48M

Total Investments

$0

XLO Income (MRY)


Revenue

$6.34M

Net Income

-$58.24M

Operating Expense

$66.93M

XLO Cash Flow (MRY)


CF Operations

-$18.38M

CF Investing

-$36.00K

CF Financing

$29.20M

XLO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

XLO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$71,075,000 (16.66%)

$60,926,000 (-56.22%)

$139,165,000 (-36.18%)

$218,060,000 (500.44%)

Assets Current

$60,234,000 (25.16%)

$48,127,000 (-61.34%)

$124,496,000 (-38.53%)

$202,517,000 (883.57%)

Assets Non-Current

$10,841,000 (-15.30%)

$12,799,000 (-12.75%)

$14,669,000 (-5.62%)

$15,543,000 (-1.17%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$17,598,000 (-52.21%)

$36,827,000 (-65.14%)

$105,647,000 (-43.03%)

$185,429,000 (322.64%)

Property Plant & Equipment Net

$9,059,000 (-18.14%)

$11,067,000 (-13.81%)

$12,840,000 (-5.57%)

$13,597,000 (-0.58%)

Cash & Equivalents

$57,073,000 (23.29%)

$46,291,000 (-62.04%)

$121,947,000 (-38.91%)

$199,606,000 (860.15%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$32,780,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,574,000 (145.14%)

$1,050,000 (-66.40%)

$3,125,000 (-0.60%)

$3,144,000 (-42.25%)

Accumulated Retained Earnings (Deficit)

-$383,753,000 (-17.89%)

-$325,512,000 (-30.67%)

-$249,108,000 (-54.84%)

-$160,886,000 (-89.09%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$8,142,000 (-34.88%)

$12,504,000 (-37.29%)

$19,939,000 (-2.91%)

$20,536,000 (-3.21%)

Debt Current

$1,188,000 (-72.76%)

$4,362,000 (-42.49%)

$7,585,000 (846.94%)

$801,000 (-72.35%)

Debt Non-Current

$6,954,000 (-14.59%)

$8,142,000 (-34.09%)

$12,354,000 (-37.40%)

$19,735,000 (7.72%)

Total Liabilities

$53,477,000 (121.91%)

$24,099,000 (-28.10%)

$33,518,000 (2.72%)

$32,631,000 (-21.56%)

Liabilities Current

$27,261,000 (70.84%)

$15,957,000 (-24.44%)

$21,119,000 (65.28%)

$12,778,000 (-42.32%)

Liabilities Non-Current

$26,216,000 (221.98%)

$8,142,000 (-34.33%)

$12,399,000 (-37.55%)

$19,853,000 (2.09%)

XLO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$6,344,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$24,778,000 (-8.22%)

$26,997,000 (-9.85%)

$29,948,000 (25.54%)

$23,856,000 (123.94%)

Research & Development Expense

$41,211,000 (-20.95%)

$52,136,000 (-11.93%)

$59,201,000 (15.65%)

$51,188,000 (16.57%)

Operating Expenses

$66,926,000 (-15.43%)

$79,133,000 (-11.24%)

$89,149,000 (18.80%)

$75,044,000 (37.54%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$58,241,000 (23.77%)

-$76,404,000 (13.40%)

-$88,222,000 (-16.39%)

-$75,800,000 (-37.27%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$58,241,000 (23.77%)

-$76,404,000 (13.40%)

-$88,222,000 (-16.39%)

-$75,800,000 (-37.27%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$58,241,000 (23.77%)

-$76,404,000 (13.40%)

-$88,222,000 (-16.39%)

-$75,800,000 (-37.27%)

Weighted Average Shares

$53,511,424 (94.61%)

$27,496,107 (0.38%)

$27,392,087 (388.59%)

$5,606,308 (970.34%)

Weighted Average Shares Diluted

$53,511,424 (94.61%)

$27,496,107 (0.38%)

$27,392,087 (388.59%)

$5,606,308 (970.34%)

Earning Before Interest & Taxes (EBIT)

-$58,241,000 (23.77%)

-$76,404,000 (13.40%)

-$88,222,000 (-16.39%)

-$75,800,000 (-37.27%)

Gross Profit

$6,344,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$60,582,000 (23.44%)

-$79,133,000 (11.24%)

-$89,149,000 (-18.80%)

-$75,044,000 (-37.54%)

XLO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$36,000 (92.59%)

-$486,000 (73.97%)

-$1,867,000 (-69.73%)

-$1,100,000 (49.73%)

Net Cash Flow from Financing

$29,196,000 (545.74%)

-$6,550,000 (-9392.75%)

-$69,000 (-100.03%)

$260,668,000 (2499.14%)

Net Cash Flow from Operations

-$18,378,000 (73.22%)

-$68,620,000 (9.38%)

-$75,723,000 (6.23%)

-$80,751,000 (-123.74%)

Net Cash Flow / Change in Cash & Cash Equivalents

$10,782,000 (114.25%)

-$75,656,000 (2.58%)

-$77,659,000 (-143.43%)

$178,817,000 (732.98%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$36,000 (92.59%)

-$486,000 (73.97%)

-$1,867,000 (-69.73%)

-$1,100,000 (49.73%)

Issuance (Repayment) of Debt Securities

-$3,382,000 (49.91%)

-$6,752,000 (-7843.53%)

-$85,000 (22.73%)

-$110,000 (-11.11%)

Issuance (Purchase) of Equity Shares

$32,578,000 (16027.72%)

$202,000 (1162.50%)

$16,000 (-99.99%)

$116,642,000 (73259.75%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,434,000 (-12.84%)

$7,382,000 (-12.37%)

$8,424,000 (69.91%)

$4,958,000 (282.56%)

Depreciation Amortization & Accretion

$1,644,000 (-13.47%)

$1,900,000 (2.87%)

$1,847,000 (23.22%)

$1,499,000 (40.75%)

XLO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-918.00%

-

-

-

EBITDA Margin

-892.10%

-

-

-

Return on Average Equity (ROAE)

-238.30% (-88.23%)

-126.60% (-94.47%)

-65.10% (56.13%)

-148.40% (-251.58%)

Return on Average Assets (ROAA)

-73.20% (17.94%)

-89.20% (-69.58%)

-52.60% (11.74%)

-59.60% (46.55%)

Return on Sales (ROS)

-918.00%

-

-

-

Return on Invested Capital (ROIC)

1397.00% (372.59%)

-512.50% (-18.61%)

-432.10% (-16.28%)

-371.60% (-40.28%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.88 (-342.42%)

-0.2 (76.29%)

-0.83 (29.42%)

-1.18

Price to Sales Ratio (P/S)

8.05

-

-

-

Price to Book Ratio (P/B)

2.38 (480.29%)

0.41 (-41.20%)

0.7 (-70.51%)

2.37

Debt to Equity Ratio (D/E)

3.04 (364.68%)

0.65 (106.31%)

0.32 (80.11%)

0.18 (135.20%)

Earnings Per Share (EPS)

-1.09 (60.79%)

-2.78 (13.66%)

-3.22 (76.18%)

-13.52 (87.18%)

Sales Per Share (SPS)

0.12 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.34 (86.31%)

-2.51 (11.30%)

-2.83 (80.60%)

-14.6 (80.02%)

Book Value Per Share (BVPS)

0.33 (-75.43%)

1.34 (-65.28%)

3.86 (-88.34%)

33.08 (120.80%)

Tangible Assets Book Value Per Share (TABVPS)

1.33 (-40.07%)

2.22 (-56.38%)

5.08 (-86.94%)

38.9 (-43.90%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

1 (120.00%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

0.22 (-47.78%)

0.43 (-21.07%)

0.54 (111.20%)

-4.83

Asset Turnover

0.08 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.21 (-26.72%)

3.02 (-48.84%)

5.89 (-62.81%)

15.85 (1606.03%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$18,414,000 (73.35%)

-$69,106,000 (10.93%)

-$77,590,000 (5.21%)

-$81,851,000 (-113.83%)

Enterprise Value (EV)

-$12,639,039 (60.28%)

-$31,817,900 (31.87%)

-$46,703,377 (-113.01%)

$358,852,168

Earnings Before Tax (EBT)

-$58,241,000 (23.77%)

-$76,404,000 (13.40%)

-$88,222,000 (-16.39%)

-$75,800,000 (-37.27%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$56,597,000 (24.03%)

-$74,504,000 (13.74%)

-$86,375,000 (-16.25%)

-$74,301,000 (-37.20%)

Invested Capital

-$5,117,000 (-145.76%)

$11,182,000 (-30.28%)

$16,038,000 (-38.81%)

$26,212,000 (79.66%)

Working Capital

$32,973,000 (2.50%)

$32,170,000 (-68.88%)

$103,377,000 (-45.52%)

$189,739,000 (12223.90%)

Tangible Asset Value

$71,075,000 (16.66%)

$60,926,000 (-56.22%)

$139,165,000 (-36.18%)

$218,060,000 (500.44%)

Market Capitalization

$41,979,961 (177.13%)

$15,148,100 (-79.50%)

$73,898,623 (-83.19%)

$439,503,168

Average Equity

$24,438,250 (-59.52%)

$60,373,500 (-55.47%)

$135,570,750 (165.46%)

$51,071,000 (190.54%)

Average Assets

$79,553,750 (-7.13%)

$85,658,000 (-48.94%)

$167,764,500 (31.90%)

$127,188,500 (156.85%)

Invested Capital Average

-$4,169,000 (-127.97%)

$14,906,750 (-26.99%)

$20,416,750 (0.08%)

$20,401,000 (-2.15%)

Shares

43,958,074 (59.60%)

27,542,000 (0.26%)

27,471,607 (0.01%)

27,468,948 (3.01%)